サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629903

ヘルスケア保護包装の世界市場 - 2025年～2033年

Global Healthcare Protective Packaging Market - 2025-2033

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヘルスケア保護包装の世界市場 - 2025年～2033年
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルスケア保護包装の世界市場は、2024年に53億米ドルに達し、2033年には84億米ドルに達し、予測期間2025年～2033年のCAGRは5.3％で成長すると予測されています。

ヘルスケア保護包装は、医薬品や医療製品を汚染、物理的損傷、光、温度、湿度などの環境要因から保護するために特別に設計されたパッケージングソリューションを指します。この種の包装は、医薬品、医療機器、生物製剤の製造、保管から流通、医療従事者や患者による使用までのサプライチェーン全体を通じて、完全性、安全性、有効性を維持する上で極めて重要です。このような特性により、ヘルスケア保護包装は規制および安全要件を満たし、サプライチェーンの全過程において、デリケートな医薬品を確実に保護します。

ヘルスケア保護包装市場は、医薬品や医療機器に対する需要の増加、パッケージング技術の先進化、製品の安全性や有効性に対する懸念の高まりなど、いくつかの要因によって牽引されています。例えば、米国国立衛生研究所によると、2023年には米国食品医薬品局（FDA）により55の新薬が承認されました。慢性疾患の増加や世界人口の高齢化は医療費の増加に寄与しており、輸送や保管中に医薬品や医療機器の完全性を確保する保護包装の必要性を高めています。

市場力学：

促進要因と抑制要因

持続可能性への注目の高まり

持続可能性への注目の高まりは、ヘルスケア保護包装市場の成長を大きく後押ししており、予測期間中も市場を牽引すると予想されます。消費者の嗜好はますます環境に優しい包装を志向するようになっています。ヘルスケア製品は特に先進国市場で世界的に使用されているため、消費者は環境への影響を最小限に抑える包装ソリューションを期待しています。リサイクル可能な材料や生分解性素材へのシフトは、企業がこうした期待に応え、持続可能性の目標を遵守するのに役立ちます。

ブリスターパックや単回投与容器には、生分解性プラスチックの使用が一般的になりつつあります。クロックナー・ペンタプラスト社、キャタレント社、ベリーグローバル社などの主要企業は、リサイクルや堆肥化が容易な材料を発売・採用することで、この移行を主導しています。

例えば、2024年10月、クロックナー・ペンタプラスト社（kp）は、kpNextブランドを医薬品用ブリスターフィルムから医療機器分野へと拡大する新しい医療機器用包装フィルム、kpNext MDR1を発売しました。この画期的な製品は、ヘルスケア包装における持続可能な包装オプションに対する需要の高まりに対応するよう設計されています。

さらに、ベリーグローバル社は2024年10月、ヘルスケア用途向けに、従来の着色PET錠剤ボトルと比較して持続可能性と製品保護を強化した透明化ポリプロピレン（PP）ボトルを発売しました。ClariPPilボトルは、ビタミン剤、栄養補助食品、美容サプリメント、OTC治療など幅広い製品に最適です。ベリーによれば、このボトルの新しい製造技術は、従来のPETボトルの射出延伸ブロー成形プロセスと比較して、CO2排出量を約71％削減します。

先進パッケージング技術は、持続可能なソリューションへの移行を促進しています。革新的な技術には、リサイクル可能なガラスや持続可能なプラスチックの開発、環境性能に妥協することなく製品の完全性を維持するためにバリア特性を強化したパッケージングなどがあります。

例えば、デュポンは2024年11月、ヘルスケア包装用タイベック製品の既存ポートフォリオを拡張し、カーボンフットプリントを大幅に削減したRA（Renewable Attribution）付きタイベックを発売し、より持続可能なヘルスケア包装の実現に貢献しました。再生可能エネルギー使用タイベックのカーボンフットプリント削減は、タイベック製造に使用される原材料の生産において、化石燃料原料の一部を認証されたバイオ循環型原材料に置き換えることで可能となります。これは、国際持続可能性カーボン認証（ISCC PLUS）に準拠したマスバランスアプローチによって達成されます。

厳格な規制への対応

厳格な規制遵守は、ヘルスケア保護包装市場の成長にとって大きな障壁です。FDAの21CFRパート11、EUのMDR、その他の地域規格などの規制要件は、材料、表示、文書に関する厳格なガイドラインを義務付けています。コンプライアンスには、多くの場合、広範な試験と認証プロセスが必要であり、メーカーにとってはコストと時間のかかるものとなります。

例えば、これらの規格を満たすために、包装会社は高度なトレーサビリティシステム、特殊な材料、滅菌技術に投資しなければならず、包装ソリューションのコストが大幅に増加する可能性があります。規制ガイドラインの変更により、包装設計を頻繁に更新する必要があることも、コスト構造をさらに複雑にしています。

厳しい承認プロセスは、新しいパッケージングソリューションの市場導入を遅らせる可能性があります。規制当局の承認取得に時間がかかるため、新製品が消費者に届くのがしばしば遅れ、競争優位性に影響を及ぼす可能性があります。例えば、EUの医療機器規制（MDR）では、メーカーは包装設計について厳格な試験を実施し、認証を取得する必要があるが、これには数年を要することがあります。このような長期のスケジュールは、企業が適合した新製品を投入するのを待たなければならないため、市場の成長を妨げる可能性があります。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • パッケージタイプ別
  • 材料別
  • 製品タイプ別
  • 用途別
  • 地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 持続可能性への注目の高まり
      • パッケージングの進歩
    • 抑制要因
      • 厳格な規制遵守
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 ヘルスケア保護包装市場、パッケージタイプ別

  • 一次包装
  • 二次包装
  • 三次包装

第6章 ヘルスケア保護包装市場、材料別

  • プラスチック
  • 紙・板紙
  • ガラス
  • アルミニウム

第7章 ヘルスケア保護包装市場、製品タイプ別

  • ボトルと容器
  • ブリスター包装
  • トレイ
  • バイアル
  • 注射器
  • その他

第8章 ヘルスケア保護包装市場、用途別

  • 医薬品
  • 医療機器
  • 診断キット
  • 栄養補助食品

第9章 ヘルスケア保護包装市場、地域別、市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • SCHOTT Pharma AG & Co. KGaA
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Gerresheimer AG
  • Amcor plc
  • Berry Global Inc.
  • West Pharmaceutical Services, Inc.
  • Smurfit Kappa
  • Sonoco Products Company
  • WestRock Company
  • DuPont
  • Pregis LLC

第12章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: PAC8932

The global healthcare protective packaging market reached US$ 5.3 billion in 2024 and is expected to reach US$ 8.4 billion by 2033, growing at a CAGR of 5.3% during the forecast period 2025-2033.

Healthcare protective packaging refers to packaging solutions specifically designed to safeguard pharmaceutical and medical products from contamination, physical damage and environmental factors such as light, temperature and humidity. This type of packaging is crucial in maintaining the integrity, safety and efficacy of drugs, medical devices and biologics throughout the supply chain from manufacturing and storage to distribution and use by healthcare providers and patients. These characteristics ensure that healthcare protective packaging meets regulatory and safety requirements and protects sensitive pharmaceutical products during the entire supply chain process.

The healthcare protective packaging market is driven by several factors, including the increasing demand for pharmaceuticals and medical devices, advancements in packaging technologies and growing concerns over product safety and efficacy. For instance, according to the National Institute of Health, in 2023, 55 new drugs were approved by the U.S. Food and Drug Administration (FDA). The rise in chronic diseases and the aging global population are contributing to higher healthcare spending, boosting the need for protective packaging that ensures the integrity of drugs and medical devices during transport and storage.

Market Dynamics: Drivers & Restraints

Rising focus on sustainability

The rising focus on sustainability is significantly driving the growth of the healthcare protective packaging market and is expected to drive the market over the forecast period. Consumer preferences are increasingly oriented towards eco-friendly packaging. As healthcare products are used globally, especially in developed markets, consumers expect packaging solutions that minimize environmental impact. The shift towards recyclable and biodegradable materials helps companies meet these expectations and comply with sustainability goals.

The use of biodegradable plastics for blister packs and single-dose containers is becoming more common. Companies like Klockner Pentaplast, Catalent and Berry Global are leading this transition by launching and adopting materials that can be easily recycled or composted.

For instance, in October 2024, Klockner Pentaplast (kp), launched kpNext MDR1, a new medical device packaging film that expands its kpNext brand beyond pharmaceutical blister films and into the medical device sector. This breakthrough product is designed to meet the growing demand for sustainable packaging options in healthcare packaging.

Additionally, in October 2024, Berry Global launched a range of clarified polypropylene (PP) bottles for healthcare applications, which offer sustainability and enhanced product protection compared to traditional colored PET pill bottles. ClariPPil bottles are ideal for a wide variety of products including vitamins, nutraceuticals, dietary supplements, beauty supplements and OTC treatments. Berry reports that its new manufacturing technology for the bottle delivers a reduction of approximately 71% in CO2 emissions compared to the traditional injection stretch blow molding process for PET bottles.

Advancements in packaging technologies are facilitating the shift towards sustainable solutions. Innovations include the development of recyclable glass and sustainable plastics, as well as packaging with enhanced barrier properties to maintain product integrity without compromising on environmental performance.

For instance, in November 2024, DuPont launched Tyvek with Renewable Attribution (RA), an extension of the existing portfolio of Tyvek products for healthcare packaging that offers a significantly reduced carbon footprint, helping to enable more sustainable healthcare packaging. The carbon footprint reduction for Tyvek with Renewable Attribution is enabled by the partial replacement of fossil fuel feedstock with certified bio-circular feedstock during the production of raw materials used in Tyvek manufacturing. This is achieved through the mass balance approach, in accordance with International Sustainability and Carbon Certification (ISCC PLUS).

Stringent regulatory compliance

Stringent regulatory compliance is a significant barrier to the growth of the healthcare protective packaging market. Regulatory requirements such as the FDA's 21 CFR Part 11, EU MDR, and other regional standards mandate strict guidelines for materials, labeling and documentation. Compliance often requires extensive testing and certification processes, which can be costly and time-consuming for manufacturers.

For instance, to meet these standards, packaging companies must invest in sophisticated traceability systems, specialized materials, and sterilization techniques, which can significantly increase the cost of packaging solutions. The need for frequent updates to packaging designs due to changes in regulatory guidelines further complicates the cost structure.

Stringent approval processes can delay the introduction of new packaging solutions to the market. The lengthy process of obtaining regulatory approvals means that new products often face delays in reaching consumers, which can impact competitive advantage. For instance, the EU's Medical Device Regulation (MDR) requires manufacturers to conduct rigorous testing and obtain certifications for packaging designs, which can take years. This extended timeline can hinder market growth as companies must wait to introduce new, compliant products.

Segment Analysis

The global healthcare protective packaging market is segmented based on packaging type, material, product type, application and region.

Material:

The plastic segment is expected to dominate the healthcare protective packaging market share

Plastics provide excellent barrier properties such as moisture, light and chemical resistance, which are critical for maintaining the integrity of pharmaceuticals and medical devices during storage and transport. Blister packs and pouches made from plastic are widely used for packaging tablets, capsules and syringes. Their ability to protect against contamination and damage makes them a preferred choice for pharmaceuticals and medical devices.

For instance, in October 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in partnership with pharma packaging specialist Liveo Research, this innovative solution reduces the carbon footprint of this packaging by 38% and marks a stride in environmental stewardship by eliminating the use of polyvinyl chloride (PVC).

Plastic is generally more cost-effective compared to other materials like glass and metal, making it suitable for mass production and meeting the demand for cost-efficient packaging solutions in the healthcare sector. Advancements in recycling technologies are making plastic a more sustainable option, especially with the development of recyclable and biodegradable plastics. Companies are increasingly adopting these solutions to meet regulatory requirements and consumer demand for greener products.

For instance, in October 2024, Placon released a new stock line of BargerGard TPU pouches and tip protectors. The new product line includes pouches with and without flaps and a variety of tip protectors to safeguard rough and sharp medical components, including catheters, needles, screws, drills and porous coated implants. The product line is made from thermoplastic polyurethane (TPU), a nonabrasive material that protects finished, polished, and other surfaces from damage, as well as preventing denting or scratching to devices and trays.

Geographical Analysis

North America is expected to hold a significant position in the healthcare protective packaging market share

North America has one of the most advanced healthcare infrastructures in the world, with well-established healthcare systems in countries like the United States and Canada. This infrastructure includes state-of-the-art facilities, a high rate of pharmaceutical consumption and a strong focus on medical research and development. These conditions necessitate high-quality protective packaging to maintain product integrity during distribution and storage.

For instance, according to the National Institute of Health (NIH), in 2021, overall pharmaceutical expenditures in the US grew 7.7% compared to 2020, for a total of $576.9 billion. Utilization (a 4.8% increase), price (a 1.9% increase) and new drugs (a 1.1% increase) drove this increase. For 2022, NIH expected overall prescription drug spending raised by 4.0% to 6.0%. This drug demand increases the demand for protective packaging in the region.

North America is at the forefront of adopting innovative packaging technologies, such as smart packaging and sustainable materials. Companies in this region are investing in technologies that provide enhanced barrier properties, tamper-evidence, and compliance with sustainability practices. This innovation drives demand for advanced protective packaging solutions across various healthcare sectors.

For instance, in November 2024, Nelipak Corporation, a leading global provider of packaging solutions for medical devices, diagnostic, pharmaceutical drug delivery, and other demanding applications, opened its first North American flexible packaging production site, in Winston-Salem, NC. The addition of the new production site will replicate Nelipak's existing capabilities to support growing customer demand in the Americas region.

Asia-Pacific is growing at the fastest pace in the healthcare protective packaging market

Asia Pacific economies are expanding rapidly with significant GDP growth, particularly in countries like China and India. This economic growth has led to increased healthcare spending as governments and consumers prioritize access to healthcare services. The rise in healthcare expenditure is directly boosting demand for protective packaging solutions to ensure the safety and efficacy of pharmaceuticals and medical devices.

For instance, China, as a major contributor to the market, is expected to see robust growth due to increased healthcare investments from both the government and private sectors. The demand for high-quality packaging materials to safeguard drugs and medical devices during distribution and storage is driving market expansion.

There is a growing awareness of environmental sustainability in the Asia Pacific, driving demand for eco-friendly packaging solutions. This is reflected in the adoption of recyclable plastics and biodegradable materials, particularly in countries like Japan, where stringent environmental regulations are in place.

For instance, in July 2024, the Council of Scientific and Industrial Research (CSIR) launched a National Mission on Sustainable Packaging Solutions. CSIR-National Institute for Interdisciplinary Science and Technology (NIIST), is tasked with coordinating the project that involves a consortium of eight partnering CSIR labs and industry partners.

Competitive Landscape

The major global players in the healthcare protective packaging market include SCHOTT Pharma AG & Co. KGaA, Gerresheimer AG, Amcor plc, Berry Global Inc., West Pharmaceutical Services, Inc., Smurfit Kappa, Sonoco Products Company, WestRock Company, DuPont, Pregis LLC and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global healthcare protective packaging market report delivers a detailed analysis with 70 key tables, more than 67 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Packaging Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Product Type
  • 2.6. Snippet by Application
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Focus on Sustainability
      • 3.1.1.2. Rising Advancements in Packaging
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent Regulatory Compliance
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Healthcare Protective Packaging Market, By Packaging Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 5.1.2. Market Attractiveness Index, By Packaging Type
  • 5.2. Primary Packaging*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Secondary Packaging
  • 5.4. Tertiary Packaging

6. Healthcare Protective Packaging Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Plastic*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Paper & Paperboard
  • 6.4. Glass
  • 6.5. Aluminium

7. Healthcare Protective Packaging Market, By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Bottles and Containers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Blister Packaging
  • 7.4. Trays
  • 7.5. Vials
  • 7.6. Syringes
  • 7.7. Others

8. Healthcare Protective Packaging Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Medical Devices
  • 8.4. Diagnostic Kits
  • 8.5. Nutraceuticals

9. Healthcare Protective Packaging Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. SCHOTT Pharma AG & Co. KGaA*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Gerresheimer AG
  • 11.3. Amcor plc
  • 11.4. Berry Global Inc.
  • 11.5. West Pharmaceutical Services, Inc.
  • 11.6. Smurfit Kappa
  • 11.7. Sonoco Products Company
  • 11.8. WestRock Company
  • 11.9. DuPont
  • 11.10. Pregis LLC

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us